Last updated on July 2018

Post Market Observational Prospective Multi-center Study

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Emphysema
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • All adult patients diagnosed with homogeneous or heterogeneous emphysema who are appropriate for Coil treatment based on the CE-Mark Approved IFU and who have been scheduled for treatment with the RePneu procedure
  • RV of >175% predicted
  • Post bronchodilator FEV1 of 45% predicted.
  • Normal international normalized ratio (INR) in the absence of anticoagulation therapy
  • Participant read, understood and signed the Informed Consent form

Exclusion Criteria:

  • Known uncontrolled pulmonary hypertension defined by systolic RVP >50mmHg
  • Giant bullae > 1/3 lung volume
  • Patients on antithrombotic treatment (except for aspirin) which cannot be stopped 7 days prior to treatment

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.